๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Effect on immunologic and other indices of adjuvant cytotoxic chemotherapy including melphalan in breast cancer

โœ Scribed by Ian R. Mackay; Michael D. Goodyear; Clare Riglar; Jennifer Penschow; Senga Whittingham; Ian S. Russell; Paul R. B. Kitchen; John P. Collins

Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
834 KB
Volume
53
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis

The authors thank Mrs. C. Richardson, SRN and Miss R. McEvey, SRN for help with patients and Miss J. Hosking and Miss L. Callegaro for their skilled technical assistance. Dr. D. C. Cowling and Dr. D. Campbell provided generous assistance with hematologic and biochemical procedures.

๐Ÿ“œ SIMILAR VOLUMES

The effect of prior adjuvant chemotherap
The effect of prior adjuvant chemotherapy on survival in metastatic breast cancer
โœ Frederick R. Ahmann; Stephen E. Jones; Thomas E. Moon ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 550 KB

Some adjuvantly treated patients develop recurrent breast cancer and little is known about the effect of prior adjuvant chemotherapy on subsequent response rates to systemic therapy or on overall survival. We describe our retrospective comparison of 179 patients who received doxorubicin containing a

The effect of postoperative and primary
The effect of postoperative and primary radiation therapy on delivered dose of adjuvant Cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) chemotherapy in breast cancer
โœ Jedd F. Levine; C. Norman Coleman; Richard S. Cox; Gordon R. Ray; William M. Rog ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 457 KB ๐Ÿ‘ 2 views

The dose of adjuvant chemotherapy for breast cancer may be an important factor in the success of the treatment program. In a retrospective analysis, the authors determined whether patients who were irradiated either postoperatively (N = 29) or as part of primary treatment (N = 13) received a lower d